Efficacy and safety of COVID-19 vaccineYANG Hui-jie, SUN Yu-fang, WANG Jun-zhi, LI Chang-gui2082-2089
Quality control strategies and challenges for gene therapy productsYU Lei, SHI Xin-chang, QIN Xi, WANG Guang-yu, LI Xiang, ZHOU Yong2090-2100
Requirements on the establishment of human induced pluripotent stem cell lines used for the development of cell-derived therapeutic productZHANG Ke-hua, NA Tao, MENG Shu-fang2101-2108
Research progress of mRNA vaccine delivery systemXING Si-xi, XU Fang-jing-wei, ZHANG Yun-tao2109-2113
Enhanced immune effect of CpG 7909/alum adjuvant to the inactivated vaccine of SARS-CoV-2YANG Rong, LI Wei-dong, LIU Xiao-juan, YUAN Guang-ying, MA Meng, ZHAO Yu-xiu, LIANG Hong-yang, ZHENG Xiao-tong2114-2119
Preparation and identification of monoclonal antibodies against human Claudin18.2ZHANG Kun-ming, LIANG Hong-yuan, CAO Chen-xin, WU Li-na, YU Yao, LU Jin, QIU Jian-hua, QU Ai-dong2120-2127
Establishment and verification of nucleic acid testing method for HBV/HCV/HIV-1 in source plasmaDENG Kun, ZHANG Lin-lin, YU Jian-hong, YANG Ling, CHEN E-xiang, TONG Jian-xiao, CHENG Yu-jing, LIU Ying, PENG Gan, ZHENG Xiao-bei, LI Pu, ZHAO Chuan-bo, PENG Dan, ZHANG Jin, WANG Yue2128-2135
Analysis of S protein cross-interference in three different corona virus strainsDONG Yuan, ZHAO Yu-xiu, ZHUGE Xiang-lin, YANG Zhao-na, LI Jie, LI Ai-ling2136-2143
Molnupiravir—an oral drug for COVID-19 and its comparative analysisZHANG Jing-wen, XU Fang-jing-wei, ZHANG Yun-tao2144-2151